[HEPATITIS C INFECTION SPECIFIC MARKERS AMONG PATIENTS WITH BREAST CANCER IN AZERBAIJAN].
The article presents results of comparative investigation of blood serum in 2682 breast cancer (BC) patients and 3323 healthy persons. At the onset of the study, all the specimens were tested for serum antibodies to hepatitis C virus (HCV). At the later stage, the serum specimens containing the antibodies were examined for detecting RNA GCV. Based on the obtained study results the authors concluded that BC patients can be considered as a high risk group for parenteral contamination with HCV. In addition, the authors have determined that HCV-infection course among BC patients is characterized by a low rate of recovery accompanied with spontaneous virus elimination and a high level of «viral load».